On-Demand Webinar

From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Learn how dosimetry, clinical pharmacology, pharmacometrics, QSP, and regulatory strategy support dose optimization for therapeutic…

Hunter Stephens, PhDJuly 17, 2026

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

CertaraJuly 16, 2026

Publication

Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

Explore how population pharmacokinetic and exposure–response modeling informed brexpiprazole dosing in Japanese patients with agitation…

CertaraJuly 16, 2026

Publication

Enhanced Bioavailability of a Novel Oil-Based Lutein Formulation: A Randomized, Double-Blind, Single-Dose, Comparative Oral Bioavailability Study in Healthy Adults

See how a randomized, double-blind study proved enhanced bioavailability of a novel oil-based lutein formulation,…

CertaraJuly 14, 2026

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

Zoe BarterJuly 13, 2026

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Matt Zierhut, PhD MBAJuly 9, 2026

On-Demand Webinar

Integrated mechanistic modeling approaches in oncology drug development

Learn how integrated QSP and PBPK modeling supports dose justification, patient stratification, and regulatory decisions…

CertaraJuly 8, 2026

Blog

AI, HTA, and the future of access: Inside the 12th annual Kraków HTA symposium

Explore key insights from the 12th Annual Kraków HTA Symposium covering HTA, reimbursement policy, AI…

Malwina Holownia, PhDJuly 8, 2026

Blog

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…

Hunter Stephens, PhDJuly 7, 2026

Publication

Population PK Modeling Supporting the Aripiprazole Two-Injection Start Regimen in Japanese Patients

Learn how population PK modeling and simulation supported a regulatory strategy for a simplified aripiprazole…

Danielle PillsburyJuly 7, 2026

Modeling and Simulation

From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

Enhanced Bioavailability of a Novel Oil-Based Lutein Formulation: A Randomized, Double-Blind, Single-Dose, Comparative Oral Bioavailability Study in Healthy Adults

When to conduct hepatic impairment studies and when modeling may be enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Integrated mechanistic modeling approaches in oncology drug development

AI, HTA, and the future of access: Inside the 12th annual Kraków HTA symposium

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Population PK Modeling Supporting the Aripiprazole Two-Injection Start Regimen in Japanese Patients

Newsletter sign up

Quick links

Solutions

Contact